NASDAQ:DRMA

Dermata Therapeutics Stock Forecast

etoro logo Buy DRMA
*Your capital is at risk
$1.27
-0.0900 (-6.62%)
At Close: Jun 03, 2026
AI Analysis AI Analysis of DRMA AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add DRMA to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Is Dermata Therapeutics, Inc. stock still a buy after falling -6.62% on Wednesday?
(Updated on Jun 03, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jun 03, 2026

The Dermata Therapeutics, Inc. stock price fell by -6.62% on the last day (Wednesday, 3rd Jun 2026) from $1.36 to $1.27. During the last trading day the stock fluctuated 8.94% from a day low at $1.23 to a day high of $1.34. The price has risen in 6 of the last 10 days and is up by 7.63% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -2 thousand shares and in total, 83 thousand shares were bought and sold for approximately $105.38 thousand.

The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Dermata Therapeutics, Inc. stock with a 90% probability to be traded between $1.12 and $1.55 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

DRMA Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Dermata Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $1.31 and $1.28. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, April 30, 2026, and so far it has fallen -7.30%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Dermata Therapeutics, Inc. stock

Dermata Therapeutics, Inc. finds support from accumulated volume at $1.26 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.110 between high and low, or 8.94%. For the last week the stock has had daily average volatility of 7.59%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (DRMA) For The Upcoming Trading Day Of Thursday 4th

For the upcoming trading day on Thursday, 4th we expect Dermata Therapeutics, Inc. to open at $1.28, and during the day (based on 14 day Average True Range), to move between $1.23 and $1.31, which gives a possible trading interval of +/-$0.0836 (+/-6.81%) up or down from last closing price. If Dermata Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 6.81% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.26 (0.79%) than the resistance at $1.46 (14.96%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Dermata Therapeutics, Inc. stock A Buy?

Dermata Therapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

Current score: -4.206 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 4, 2026 - $1.28 ( 0.787%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

DRMA Performance

Trading levels for DRMA

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 1.39 9.45%
R2 1.35 6.14%
R1 1.32 4.10%
Price 1.27
S1 1.24 -2.52%
S2 1.21 -4.57%
S3 1.17 -7.87%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.57 23.62%
R2 1.55 22.05%
R1 1.46 14.96%
Price 1.27
S1 1.26 -0.787%
S2 1.21 -4.72%
S3 1.18 -7.09%

FAQ

What is the symbol for Dermata Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Dermata Therapeutics, Inc. is DRMA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Dermata Therapeutics, Inc. Stock?
Dermata Therapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

How to buy Dermata Therapeutics, Inc. Stock?
Dermata Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Dermata Therapeutics, Inc. Stock.

What's the current price of Dermata Therapeutics, Inc. Stock?
As of the end of day on the Jun 03, 2026, the price of an Dermata Therapeutics, Inc. (DRMA) share was $1.27.

What is the 52-week high and low for Dermata Therapeutics, Inc. Stock?
The 52-week high for Dermata Therapeutics, Inc. Stock is $7.14 and the 52-week low is $0.581.

What is the market capitalization of Dermata Therapeutics, Inc. Stock?
As of the Jun 03, 2026, the market capitalization of Dermata Therapeutics, Inc. is 865.577K.

When is the next earnings date for Dermata Therapeutics, Inc.?
The upcoming earnings date for Dermata Therapeutics, Inc. is Aug 18, 2026.
Click to get the best stock tips daily for free!
ABOUT DERMATA THERAPEUTICS, INC.
Dermata Therapeutics
Dermata Therapeutics, Inc., a clinical-stage biotechnology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions. The company's lead product candidate is DMT310, which has completed Phase IIb clinical trial for treatment of moderate-to-severe acne; and Phase Ib proof of concept (POC) trial for Mild-to-Moderate Psoriasis, as well as is in a Phas...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE